Income Taxes (Tables)

12 Months Ended

Dec. 31, 2025

Income Taxes [Abstract]

Schedule of Deferred Tax Assets and Liabilities

Significant components of the Company deferred tax assets and liabilities are as follows:

	December 31,
	2025			2024
Net operating loss carryforward	$	3,667,668		$	2,066,962
Research and development expenses		308,267			205,513
Provision for warranty		3,450			3,450
Provision for vacation and convalescence		84,486			82,579
Provision for severance, net		64,333			60,911
Provision for credit losses		203,876			186,377
Issuance cost		-			203,045
Operating lease liabilities		82,438			109,368
Deferred tax assets before valuation allowance		4,414,518			2,918,205
Valuation allowance		(4,332,080	)		(2,808,837	)
Net deferred tax assets		82,438			109,368
Operating lease right of use assets		(82,438	)		(109,368	)
Total deferred tax liability		(82,438	)		(109,368	)
Net deferred tax assets	$	-		$	-

Schedule of Net Changes in the Total Valuation Allowance

The net changes in the total valuation allowance as of December 31, 2025 and 2024, are comprised as follows:

	December 31,
	2025		2024
Balance at beginning of year	$	2,918,205	$	2,473,359
Additions during the year		1,496,313		444,846
Balance at the end of year	$	4,414,518	$	2,918,205

Schedule of Reconciliation of the Provision for Income Taxes

A reconciliation of the provision for income taxes to the amount computed by applying the 23% statutory Israeli income tax rate to income before income taxes after the adoption of ASU 2023-09 is as follows:

	December 31, 2025
	Amount			%
Tax at Israeli Statutory Rate	$	(1,244,144	)		23	%
Changes in valuation allowances		721,001			13	%
Non-taxable or non-deductible items: Foreign exchange differences		(94,188	)		2	%
Other		42,752			1	%
Preferred Technological Enterprise tax		574,579			11	%
Balance at the end of year	$	-			0	%